From dietary exposure to systemic toxicity: organ-on-chip and multi-organ microphysiological systems for green food toxicology
Organ-on-chip models could connect dietary exposure, metabolism, and organ injury in more human-relevant food safety tests.
2026-09-16
Qureator
Qureator develops Curiochips, a three-dimensional organ-on-chip platform for modeling human biology. The company combines engineered tissue systems with data analysis to study disease and treatment responses during preclinical drug development.
2026-09-14
DLOC Biosystems
DLOC Biosystems develops organ-on-chip devices and automated systems for connecting multiple tissue models. Its platforms combine three-dimensional scaffolds, controlled fluid handling and tissue measurements to support preclinical studies of drug effects and organ interactions.
2026-09-14
Syntopia
Syntopia combines microfluidic systems, perfused human tissue cultures and computational models to study drug responses. Its platform generates spatial and temporal measurements from three-dimensional models, with a focus on evaluating antibody-drug conjugates before clinical testing.
2026-09-14
TissUse
TissUse develops HUMIMIC multi-organ-chip systems that connect human tissue models under controlled conditions. Its platforms and research services support investigations of compound metabolism, toxicity and interactions between organs during preclinical testing.
2026-09-14
NanoCellect
NanoCellect develops microfluidic flow-cytometry instruments for analyzing and sorting cells. Its WOLF platform uses disposable microfluidic cartridges to support single-cell research, cell-line development and other experiments that need selected populations of viable cells.
2026-09-14
Nicoya
Nicoya develops biosensing instruments for studying how molecules bind and interact. Its Alto platform combines digital microfluidics with surface plasmon resonance, allowing researchers to characterize molecular interactions using small samples in automated assay workflows.
2026-09-14
Kytopen
Kytopen develops Flowfect, a cell-engineering platform that combines microfluidic flow with electric fields to deliver genetic payloads into cells. The MIT spinout designs its tools to connect early research with larger-scale cell-therapy manufacturing.
2026-09-14
Indee Labs
Indee Labs develops Hydropore, a microfluidic platform for delivering genetic material and other payloads into immune cells. It uses vortex-driven physical processing to support non-viral cell engineering, with research-use tools for developing cell therapies.
2026-09-14
Hooke Bio
Hooke Bio develops microfluidic screening systems for preclinical research. Its technology supports small-volume experiments with three-dimensional microtissues, helping laboratories study drug responses and combinations while reducing the liquid handling required by conventional screening workflows.
2026-09-14
Bi/ond
Bi/ond develops customizable organ-on-chip platforms for dynamic three-dimensional cell culture. The Delft company combines microfabrication and controlled culture environments to support disease models, tissue research and drug testing with more realistic human biological conditions.
2026-09-14
Phlotonics
Phlotonics develops silicon photonic biosensors for label-free protein measurement. Its chip-based systems monitor biological molecules during bioprocessing, helping researchers and manufacturers follow changes in protein concentrations without waiting for conventional laboratory assays.
2026-09-14